Demcizumab
M18-005
Phase 1 small_molecule terminated
Quick answer
Demcizumab for Primary Peritoneal Carcinoma is a Phase 1 program (small_molecule) at Mereo BioPharma Group plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mereo BioPharma Group plc
- Indication
- Primary Peritoneal Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated